Menu
Back to Journals » OncoTargets and Therapy » Volume 15
Review
Profile of Margetuximab: Evidence to Date in the Targeted Treatment of Metastatic HER2-positive Breast Cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,307 | Dovepress* | 5,721+ | 293 | 6,014 | |
| PubMed Central* | 1,586 | 216 | 1,802 | ||
| Totals | 7,307 | 509 | 7,816 | ||
| *Since 28 April 2022 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 1 |
View citations on PubMed Central and Google Scholar